David P. Paul's most recent trade in Sutro Biopharma Inc was a trade of 675 Common Stock done . Disclosure was reported to the exchange on March 4, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sutro Biopharma Inc | David Pauling | Chief Admin. Ofcr. & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2026 | 675 | 10,025 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | David Pauling | Chief Admin. Ofcr. & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2026 | 675 | 0 | - | - | Restricted Stock Units (RSUs) | |
| Sutro Biopharma Inc | David Pauling | Chief Admin. Ofcr. & GC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.31 per share. | 04 Mar 2026 | 277 | 9,748 (0%) | 0% | 21.3 | 5,903 | Common Stock |
| Sutro Biopharma Inc | David Pauling | Chief Admin. Ofcr. & GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2026 | 33,600 | 33,600 | - | - | Stock Option (right to buy) | |
| Sutro Biopharma Inc | David Pauling | Chief Admin. Ofcr. & GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2026 | 4,200 | 4,200 | - | - | Restricted Stock Units (RSUs) | |
| Sutro Biopharma Inc | David Pauling | Chief Admin. Ofcr. & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2026 | 2,356 | 10,320 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | David Pauling | Chief Admin. Ofcr. & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2026 | 2,356 | 7,069 | - | - | Restricted Stock Units (RSUs) | |
| Sutro Biopharma Inc | David Pauling | Chief Admin. Ofcr. & GC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.55 per share. | 01 Mar 2026 | 970 | 9,350 (0%) | 0% | 20.6 | 19,934 | Common Stock |
| Sutro Biopharma Inc | David Pauling | Chief Admin. Ofcr. & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2026 | 842 | 8,515 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | David Pauling | Chief Admin. Ofcr. & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2026 | 842 | 1,686 | - | - | Restricted Stock Units (RSUs) | |
| Sutro Biopharma Inc | David Pauling | Chief Admin. Ofcr. & GC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.47 per share. | 01 Mar 2026 | 551 | 7,964 (0%) | 0% | 20.5 | 11,279 | Common Stock |
| Sutro Biopharma Inc | David Pauling | Chief Admin. Ofcr. & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2026 | 500 | 7,673 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | David Pauling | Chief Admin. Ofcr. & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2026 | 500 | 500 | - | - | Restricted Stock Units (RSUs) | |
| Corteva | David Paul Johnson | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2026 | 24,112 | 81,827 (0%) | 0% | 0 | Common Stock | |
| Corteva | David Paul Johnson | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.59 per share. | 18 Feb 2026 | 704 | 57,715 (0%) | 0% | 76.6 | 53,919 | Common Stock |
| Zurn Elkay Water Soln Corp | David J. Pauli | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 51.61 per share. | 11 Feb 2026 | 812 | 65,995 (0%) | 0% | 51.6 | 41,907 | Common Stock |
| Zurn Elkay Water Soln Corp | David J. Pauli | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2026 | 15,778 | 74,446 (0%) | 0% | - | Common Stock | |
| Zurn Elkay Water Soln Corp | David J. Pauli | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 51.80 per share. | 06 Feb 2026 | 7,639 | 66,807 (0%) | 0% | 51.8 | 395,700 | Common Stock |
| Amarin Corp (ADR) | David Paul Keenan | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2026 | 30,060 | 30,060 | - | - | Stock Option (right to buy) | |
| Amarin Corp (ADR) | David Paul Keenan | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2026 | 8,013 | 8,013 | - | - | Restricted Stock Unit | |
| Amarin Corp (ADR) | David Paul Keenan | EVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2026 | 2,246 | 11,958 (0%) | 0% | - | American Depositary Shares | |
| Amarin Corp (ADR) | David Paul Keenan | EVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2026 | 2,246 | 0 | - | - | Restricted Stock Unit | |
| Amarin Corp (ADR) | David Paul Keenan | EVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2026 | 1,933 | 12,718 (0%) | 0% | - | American Depositary Shares | |
| Amarin Corp (ADR) | David Paul Keenan | EVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2026 | 1,933 | 1,933 | - | - | Restricted Stock Unit | |
| Amarin Corp (ADR) | David Paul Keenan | EVP, Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.42 per share. | 31 Jan 2026 | 1,173 | 10,785 (0%) | 0% | 15.4 | 18,088 | American Depositary Shares |
| Amarin Corp (ADR) | David Paul Keenan | EVP, Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.42 per share. | 31 Jan 2026 | 1,010 | 11,708 (0%) | 0% | 15.4 | 15,574 | American Depositary Shares |
| Globus Medical Inc (Class A) | David C. Paul | Director, Executive Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2026 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Amarin Corp (ADR) | David Paul Keenan | EVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2026 | 3,688 | 11,638 (0%) | 0% | - | American Depositary Shares | |
| Amarin Corp (ADR) | David Paul Keenan | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 3,688 | 3,688 | - | - | Restricted Stock Unit | |
| Amarin Corp (ADR) | David Paul Keenan | EVP, Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.96 per share. | 02 Jan 2026 | 1,926 | 9,712 (0%) | 0% | 14.0 | 26,887 | American Depositary Shares |
| Sutro Biopharma Inc | David Pauling | Chief Admin. Ofcr. & GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 7,200 | 7,200 | - | - | Stock Option (right to buy) | |
| Comstock Holding Co. Inc (Class A) | David P. Paul | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2025 | 856 | 13,926 (0%) | 0% | 0 | Class A Common Stock, $0.01 par value | |
| Globus Medical Inc (Class A) | David C. Paul | Director, Executive Chairman, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 34,375 | 0 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc (Class A) | David C. Paul | Director, Executive Chairman, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.52 per share. | 08 Dec 2025 | 34,375 | 60,417 (0%) | 0% | 25.5 | 877,250 | Class A Common Stock |
| QuinStreet Inc | David J. Pauldine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 9,938 | 186,765 (0%) | 0% | 0 | Common Stock | |
| Heartland Express Inc | David Paul Millis | Director, President of Millis Transfer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Oct 2025 | 11,947 | 60,665 (0%) | 0% | 0 | Common Stock | |
| Heartland Express Inc | David Paul Millis | Director, President of Millis Transfer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.37 per share. | 22 Oct 2025 | 3,929 | 56,736 (0%) | 0% | 8.4 | 32,886 | Common Stock |
| Sutro Biopharma Inc | David Pauling | Chief Admin. Ofcr. & GC | Purchase of securities on an exchange or from another person at price $ 0.80 per share. | 15 Oct 2025 | 12,504 | 71,737 (0%) | 0% | 0.8 | 9,993 | Common Stock |
| Corteva | David Paul Johnson | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.88 per share. | 16 Sep 2025 | 6,754 | 58,312 (0%) | 0% | 69.9 | 471,970 | Common Stock |
| Comstock Holding Co. Inc (Class A) | David P. Paul | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2025 | 621 | 13,070 (0%) | 0% | 0 | Class A Common Stock, $0.01 par value | |
| Zurn Elkay Water Soln Corp | David J. Pauli | Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Aug 2025 | 1,691 | 58,668 (0%) | 0% | 0 | Common Stock | |
| Zurn Elkay Water Soln Corp | David J. Pauli | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.79 per share. | 11 Jul 2025 | 1,090 | 60,359 (0%) | 0% | 37.8 | 41,191 | Common Stock |
| QuinStreet Inc | David J. Pauldine | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Jun 2025 | 169,923 | 0 (0%) | 0% | 0 | Common Stock | |
| QuinStreet Inc | David J. Pauldine | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Jun 2025 | 169,923 | 176,827 (0%) | 0% | 0 | Common Stock | |
| Comstock Holding Co. Inc (Class A) | David P. Paul | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 1,010 | 12,449 (0%) | 0% | 0 | Class A Common Stock, $0.01 par value | |
| Zurn Elkay Water Soln Corp | David J. Pauli | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.67 per share. | 14 May 2025 | 4,068 | 63,478 (0%) | 0% | 12.7 | 51,542 | Common Stock |
| Zurn Elkay Water Soln Corp | David J. Pauli | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2025 | 4,068 | 0 | - | - | Stock Option (right to buy) | |
| Zurn Elkay Water Soln Corp | David J. Pauli | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 37.11 per share. | 14 May 2025 | 2,706 | 60,772 (0%) | 0% | 37.1 | 100,420 | Common Stock |
| Farmers National Banc Corp | David Paull | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2025 | 1,778 | 53,135 (0%) | 0% | 0 | Farmers National Banc Corp. Common Stock | |
| Sutro Biopharma Inc | David Pauling | Chief Admin. Ofcr. & GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2025 | 101,500 | 101,500 | - | - | Stock Option (Right to Buy) | |
| Sutro Biopharma Inc | David Pauling | Chief Admin. Ofcr. & GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2025 | 94,250 | 94,250 | - | - | Restricted Stock Units (RSUs) | |
| Comstock Holding Co. Inc (Class A) | David P. Paul | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 1,506 | 11,439 (0%) | 0% | 0 | Class A Common Stock, $0.01 par value | |
| Corteva | David Paul Johnson | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 18,480 | 18,480 | - | - | Non-Qualified Stock Option (right-to-buy) | |
| Corteva | David Paul Johnson | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 6,826 | 64,573 (0%) | 0% | 0 | Common Stock | |
| Zurn Elkay Water Soln Corp | David J. Pauli | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 20,870 | 67,800 (0%) | 0% | - | Common Stock | |
| Zurn Elkay Water Soln Corp | David J. Pauli | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 35.47 per share. | 14 Feb 2025 | 8,390 | 59,410 (0%) | 0% | 35.5 | 297,593 | Common Stock |
| Zurn Elkay Water Soln Corp | David J. Pauli | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.99 per share. | 10 Feb 2025 | 642 | 46,930 (0%) | 0% | 38.0 | 24,390 | Common Stock |
| Globus Medical Inc (Class A) | David C. Paul | Director, Executive Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Heartland Express Inc | Paul Millis David | Director, President of Millis Transfer | Grant, award, or other acquisition of securities at price $ 11.57 per share. | 19 Dec 2024 | 8,489 | 48,718 (0%) | 0% | 11.6 | 98,218 | Common Stock |
| Comstock Holding Co. Inc (Class A) | David P. Paul | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2024 | 1,181 | 9,933 (0%) | 0% | 0 | Class A Common Stock, $0.01 par value | |
| Globus Medical Inc (Class A) | David C. Paul | Director, Executive Chairman, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.10 per share. | 15 Nov 2024 | 26,042 | 26,042 (0%) | 0% | 24.1 | 627,612 | Class A Common Stock |
| Globus Medical Inc (Class A) | David C. Paul | Director, Executive Chairman, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 26,042 | 0 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Zurn Elkay Water Soln Corp | David J. Pauli | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2024 | 8,320 | 51,642 (0%) | 0% | - | Common Stock | |
| Zurn Elkay Water Soln Corp | David J. Pauli | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 39.15 per share. | 06 Nov 2024 | 4,070 | 47,572 (0%) | 0% | 39.2 | 159,341 | Common Stock |
| QuinStreet Inc | David J. Pauldine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2024 | 6,904 | 6,904 (0%) | 0% | 0 | Common Stock | |
| QuinStreet Inc | David J. Pauldine | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Oct 2024 | 14,471 | 0 (0%) | 0% | 0 | Common Stock | |
| QuinStreet Inc | David J. Pauldine | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Oct 2024 | 14,471 | 169,923 (0%) | 0% | 0 | Common Stock | |
| Zurn Elkay Water Soln Corp | David J. Pauli | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.38 per share. | 05 Oct 2024 | 326 | 43,322 (0%) | 0% | 36.4 | 11,860 | Common Stock |
| Corteva | David Paul Johnson | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2024 | 57,581 | 57,581 (0%) | 0% | 0 | Common Stock | |
| Corteva | David Paul Johnson | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2024 | 23,606 | 23,606 | - | - | Non-Qualified Stock Option (right to buy) | |
| Comstock Holding Co. Inc (Class A) | David P. Paul | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Sep 2024 | 1,367 | 8,752 (0%) | 0% | 0 | Class A Common Stock, $0.01 par value | |
| QuinStreet Inc | David J. Pauldine | Director | Sale or transfer of securities back to the company at price $ 17.59 per share. | 21 Aug 2024 | 10,099 | 155,452 (0%) | 0% | 17.6 | 177,641 | Common Stock |
| QuinStreet Inc | David J. Pauldine | Director | Sale of securities on an exchange or to another person at price $ 17.59 per share. | 21 Aug 2024 | 10,099 | 155,452 (0%) | 0% | 17.6 | 177,641 | Common Stock |
| QuinStreet Inc | David J. Pauldine | Director | Sale or transfer of securities back to the company at price $ 17.55 per share. | 21 Aug 2024 | 601 | 165,551 (0%) | 0% | 17.6 | 10,548 | Common Stock |
| QuinStreet Inc | David J. Pauldine | Director | Sale of securities on an exchange or to another person at price $ 17.55 per share. | 21 Aug 2024 | 601 | 165,551 (0%) | 0% | 17.6 | 10,548 | Common Stock |
| QuinStreet Inc | David J. Pauldine | Director | Sale or transfer of securities back to the company at price $ 17.56 per share. | 21 Aug 2024 | 300 | 166,152 (0%) | 0% | 17.6 | 5,268 | Common Stock |
| QuinStreet Inc | David J. Pauldine | Director | Sale of securities on an exchange or to another person at price $ 17.56 per share. | 21 Aug 2024 | 300 | 166,152 (0%) | 0% | 17.6 | 5,268 | Common Stock |
| Zurn Elkay Water Soln Corp | David J. Pauli | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.00 per share. | 11 Jul 2024 | 743 | 42,779 (0%) | 0% | 30 | 22,290 | Common Stock |
| QuinStreet Inc | David J. Pauldine | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Jun 2024 | 12,708 | 14,471 (0%) | 0% | 0 | Common Stock | |
| QuinStreet Inc | David J. Pauldine | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Jun 2024 | 12,708 | 166,452 (0%) | 0% | 0 | Common Stock | |
| Comstock Holding Co. Inc (Class A) | David P. Paul | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 1,661 | 7,385 (0%) | 0% | 0 | Class A Common Stock, $0.01 par value | |
| Farmers National Banc Corp | David Paull | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2024 | 1,384 | 50,814 (0%) | 0% | 0 | Farmers National Banc Corp. Common Stock | |
| Atkore Inc | David Paul Johnson | Vice President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 16 | 32,502 (0%) | 0% | 0 | Common Stock | |
| Atkore Inc | David Paul Johnson | Vice President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 15 | 32,486 (0%) | 0% | 0 | Common Stock | |
| Comstock Holding Co. Inc (Class A) | David P. Paul | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 2,253 | 5,724 (0%) | 0% | 0 | Class A Common Stock, $0.01 par value | |
| Atkore Inc | David Paul Johnson | Vice President and CFO | Sale of securities on an exchange or to another person at price $ 172.84 per share. | 04 Mar 2024 | 12,701 | 32,471 (0%) | 0% | 172.8 | 2,195,228 | Common Stock |
| Globus Medical Inc (Class A) | C. David Paul | Director, Executive Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2024 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Comstock Holding Co. Inc (Class A) | P. David Paul | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2023 | 2,638 | 3,471 (0%) | 0% | 0 | Class A Common Stock, $0.01 par value | |
| Globus Medical Inc (Class A) | David Paul C. | Director, Executive Chairman, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Dec 2023 | 342,200 | 20,525,324 | - | - | Class B Common Stock | |
| Globus Medical Inc (Class A) | Paul David C. | Director, Executive Chairman, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Dec 2023 | 171,100 | 171,100 | - | - | Class B Common Stock | |
| Globus Medical Inc (Class A) | Paul David C. | Director, Executive Chairman, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Dec 2023 | 171,100 | 171,100 | - | - | Class B Common Stock | |
| Heartland Express Inc | Paul David Millis | Director, President of Millis Transfer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2023 | 7,513 | 40,229 (0%) | 0% | 0 | Common Stock | |
| Atkore Inc | David Paul Johnson | Vice President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2023 | 20,905 | 54,041 (0%) | 0% | 0 | Common Stock | |
| Atkore Inc | David Paul Johnson | Vice President and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.41 per share. | 17 Nov 2023 | 8,869 | 45,172 (0%) | 0% | 131.4 | 1,165,475 | Common Stock |
| Atkore Inc | David Paul Johnson | Vice President and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.41 per share. | 17 Nov 2023 | 890 | 33,136 (0%) | 0% | 131.4 | 116,955 | Common Stock |
| Atkore Inc | David Paul Johnson | Vice President and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 135.23 per share. | 16 Nov 2023 | 367 | 34,026 (0%) | 0% | 135.2 | 49,629 | Common Stock |
| Atkore Inc | David Paul Johnson | Vice President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2023 | 4,749 | 34,393 (0%) | 0% | 0 | Common Stock | |
| Atkore Inc | David Paul Johnson | Vice President and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 132.29 per share. | 11 Nov 2023 | 470 | 29,644 (0%) | 0% | 132.3 | 62,176 | Common Stock |
| QuinStreet Inc | David J. Pauldine | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Jun 2023 | 12,500 | 22,646 (0%) | 0% | 0 | Common Stock | |
| QuinStreet Inc | David J. Pauldine | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Jun 2023 | 12,500 | 143,806 (0%) | 0% | 0 | Common Stock | |
| QuinStreet Inc | David J. Pauldine | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Jun 2023 | 12,500 | 131,306 (0%) | 0% | 0 | Common Stock |